Statistics

Total Visits

	Views
Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial	73

File Visits

	Downloads
7415-31389.pdf	23

Select a period of time:

Number of views in the range

	Views
Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial	42

Number of downloads in the range

	Downloads
7415-31389.pdf	1

Views

	Views
April 2025	1
May 2025	7
June 2025	9
July 2025	16
August 2025	1
September 2025	6
October 2025	2

untranslated

untranslated

Number of downloads in the period of time

Downloads
April 2025

0
May 2025

0
June 2025

0
July 2025

0
August 2025

0
September 2025

1
October 2025

0

untranslated

untranslated

Top country views

	Views
Singapore	15
Brazil	11
United States	6
Germany	2
Canada	1
Chile	1
Ecuador	1
United Kingdom	1
Hong Kong	1
Tunisia	1

Top countries by downloads

	Downloads
United States	1

Top cities views

	Views
Aachen	1
Ariquemes	1
Averill Park	1
Cafelândia	1
Camaragibe	1
Council Bluffs	1
Dallas	1
Garibaldi	1
Guayaquil	1
Hong Kong	1

Top cities by downloads

	Downloads